Investment Portfolio | |||||||
(UNAUDITED) | 07.31.2023 | |||||||
CARILLON EAGLE SMALL CAP GROWTH FUND | |||||||
COMMON STOCKS - 99.2% | Shares | Value | |||||
Aerospace & defense - 3.0% | |||||||
AeroVironment, Inc.* | 55,803 | $ | 5,315,794 | ||||
Woodward, Inc. | 115,257 | 13,874,637 | |||||
Beverages - 2.7% | |||||||
Celsius Holdings, Inc.* | 121,063 | 17,517,816 | |||||
Biotechnology - 8.4% | |||||||
89bio, Inc.*(a) | 219,439 | 3,475,914 | |||||
ACELYRIN, Inc.* | 174,987 | 4,346,677 | |||||
Aldeyra Therapeutics, Inc.* | 300,688 | 2,440,083 | |||||
Alkermes PLC* | 196,442 | 5,751,822 | |||||
Arrowhead Pharmaceuticals, Inc.* | 161,574 | 5,577,535 | |||||
Blueprint Medicines Corp.* | 66,220 | 4,370,520 | |||||
Cytokinetics, Inc.* | 120,109 | 4,005,635 | |||||
Denali Therapeutics, Inc.* | 92,140 | 2,619,540 | |||||
Halozyme Therapeutics, Inc.* | 129,331 | 5,556,060 | |||||
Insmed, Inc.* | 159,493 | 3,523,200 | |||||
Intellia Therapeutics, Inc.* | 78,327 | 3,315,582 | |||||
Karuna Therapeutics, Inc.* | 8,483 | 1,694,649 | |||||
Vaxcyte, Inc.* | 104,115 | 5,003,767 | |||||
Viridian Therapeutics, Inc.* | 126,653 | 2,376,010 | |||||
Building products - 1.6% | |||||||
Zurn Elkay Water Solutions Corp. | 337,593 | 10,276,331 | |||||
Capital markets - 3.7% | |||||||
LPL Financial Holdings, Inc. | 32,330 | 7,415,209 | |||||
PJT Partners, Inc., Class A | 207,377 | 16,447,070 | |||||
Chemicals - 3.6% | |||||||
Livent Corp.* | 313,617 | 7,721,251 | |||||
Quaker Houghton | 77,814 | 15,592,369 | |||||
Commercial services & supplies - 6.1% | |||||||
Casella Waste Systems, Inc., Class A* | 62,541 | 5,046,433 | |||||
MSA Safety, Inc. | 86,310 | 14,327,460 | |||||
RB Global, Inc. | 313,710 | 20,228,021 | |||||
Construction materials - 2.8% | |||||||
Summit Materials, Inc., Class A* | 496,799 | 17,974,188 | |||||
Consumer finance - 1.7% | |||||||
FirstCash Holdings, Inc. | 113,725 | 10,835,718 | |||||
Consumer staples distribution - 1.0% | |||||||
Casey's General Stores, Inc. | 26,289 | 6,642,179 | |||||
Diversified consumer services - 0.8% | |||||||
OneSpaWorld Holdings Ltd.* | 379,273 | 4,871,762 | |||||
Electrical equipment - 2.4% | |||||||
nVent Electric PLC | 99,885 | 5,281,919 | |||||
Thermon Group Holdings, Inc.* | 378,802 | 10,458,723 | |||||
Energy equipment & services - 1.9% | |||||||
Liberty Energy, Inc. | 737,481 | 12,146,312 | |||||
Food products - 1.7% | |||||||
Freshpet, Inc.* | 53,391 | 3,926,374 | |||||
The Simply Good Foods Co.* | 185,881 | 7,195,454 | |||||
Ground transportation - 2.4% | |||||||
Landstar System, Inc. | 77,285 | 15,734,453 | |||||
Health care equipment & supplies - 6.5% | |||||||
CONMED Corp. | 23,725 | 2,871,911 | |||||
Haemonetics Corp.* | 79,998 | 7,379,015 | |||||
Inmode Ltd.* | 78,526 | 3,369,551 | |||||
Inspire Medical Systems, Inc.* | 17,728 | 5,102,296 | |||||
iRhythm Technologies, Inc.* | 25,404 | 2,668,944 | |||||
Lantheus Holdings, Inc.* | 104,465 | 9,035,178 | |||||
Merit Medical Systems, Inc.* | 109,334 | 8,163,970 | |||||
Shockwave Medical, Inc.* | 13,210 | 3,442,526 | |||||
Health care providers & services - 2.2% | |||||||
Guardant Health, Inc.* | 83,376 | 3,253,331 | |||||
HealthEquity, Inc.* | 47,834 | 3,249,842 | |||||
Progyny, Inc.* | 99,084 | 4,137,748 | |||||
The Ensign Group, Inc. | 33,756 | 3,269,944 | |||||
Health care technology - 1.6% | |||||||
Evolent Health, Inc., Class A* | 239,070 | 7,265,337 | |||||
Schrodinger, Inc.* | 55,310 | 2,893,266 | |||||
Hotels, restaurants & leisure - 7.0% | |||||||
Cava Group, Inc.*(a) | 78,506 | 4,483,478 | |||||
Everi Holdings, Inc.* | 400,269 | 5,939,992 | |||||
Planet Fitness, Inc., Class A* | 165,728 | 11,193,269 | |||||
SeaWorld Entertainment, Inc.* | 163,124 | 9,032,176 | |||||
Wingstop, Inc. | 43,221 | 7,286,196 | |||||
Xponential Fitness, Inc., Class A* | 343,827 | 7,261,626 | |||||
Industrial real estate investment trusts (REITs) - 1.9% | |||||||
EastGroup Properties, Inc. | 67,797 | 12,012,272 | |||||
Insurance - 2.0% | |||||||
Kinsale Capital Group, Inc. | 35,447 | 13,208,616 | |||||
Interactive media & services - 0.8% | |||||||
Bumble, Inc., Class A* | 293,339 | 5,432,638 | |||||
Life sciences tools & services - 0.4% | |||||||
Medpace Holdings, Inc.* | 10,486 | 2,654,741 | |||||
Machinery - 3.0% | |||||||
Chart Industries, Inc.* | 47,753 | 8,698,686 | |||||
Esab Corp. | 104,624 | 7,187,669 | |||||
Federal Signal Corp. | 57,110 | 3,488,850 | |||||
Media - 0.5% | |||||||
TechTarget, Inc.* | 89,806 | 2,916,899 | |||||
Oil, gas & consumable fuels - 4.8% | |||||||
Antero Resources Corp.* | 134,897 | 3,608,495 | |||||
Chord Energy Corp. | 40,032 | 6,278,619 | |||||
Viper Energy Partners LP | 773,095 | 20,966,336 | |||||
Personal care products - 0.7% | |||||||
elf Beauty, Inc.* | 39,920 | 4,659,462 | |||||
Pharmaceuticals - 1.2% | |||||||
Intra-Cellular Therapies, Inc.* | 125,924 | 7,787,140 | |||||
Semiconductors & semiconductor equipment - 6.1% | |||||||
Ambarella, Inc.* | 35,642 | 2,973,256 | |||||
Impinj, Inc.* | 42,161 | 2,808,766 | |||||
Lattice Semiconductor Corp.* | 186,231 | 16,935,847 | |||||
Silicon Laboratories, Inc.* | 109,394 | 16,315,021 | |||||
Software - 10.3% | |||||||
Appfolio, Inc., Class A* | 32,299 | 5,832,877 | |||||
Confluent, Inc., Class A* | 94,597 | 3,267,380 | |||||
Five9, Inc.* | 75,204 | 6,599,151 | |||||
Freshworks, Inc., Class A* | 611,776 | 11,415,740 | |||||
Monday.com Ltd.* | 57,026 | 10,309,160 | |||||
PROS Holdings, Inc.* | 221,568 | 8,419,584 | |||||
Rapid7, Inc.* | 83,628 | 3,839,362 | |||||
Smartsheet, Inc., Class A* | 197,137 | 8,752,883 | |||||
Sprout Social, Inc., Class A* | 134,295 | 7,673,616 | |||||
Specialty retail - 2.8% | |||||||
Boot Barn Holdings, Inc.* | 85,439 | 8,022,722 | |||||
Five Below, Inc.* | 46,910 | 9,773,229 | |||||
Technology hardware, storage & peripherals - 1.3% | |||||||
Super Micro Computer, Inc.* | 25,201 | 8,323,134 | |||||
Trading companies & distributors - 2.3% | |||||||
Herc Holdings, Inc. | 42,942 | 5,746,928 | |||||
WESCO International, Inc. | 52,913 | 9,289,935 | |||||
Total common stocks (cost $472,642,054) | 639,385,077 | ||||||
MONEY MARKET FUNDS - 0.6% | |||||||
First American Government Obligations Fund - Class X, 5.18%# | 3,950,960 | 3,950,960 | |||||
Total money market funds (cost $3,950,960) | 3,950,960 | ||||||
Total investment portfolio (cost $476,593,014) - 99.8% | 643,336,037 | ||||||
Other assets in excess of liabilities - 0.2% | 1,110,531 | ||||||
Total net assets - 100.0% | $ | 644,446,568 |
* Non-income producing security | ||||
(a) All or a portion of this security was on loan as of the date of this report. The total fair market value of loaned securities was $4,177,631 or 0.6% of net assets as of the date of this report. | ||||
# Annualized seven-day yield as of the date of this report. Investment made with cash collateral received for securities on loan. | ||||
Fair value measurements | The Fund utilizes a three-level hierarchy of inputs to establish a classification of fair value measurements. The three levels are defined as: | ||||
Level 1—Valuations based on unadjusted quoted prices for identical securities in active markets; | ||||
Level 2—Valuations based on inputs other than quoted prices that are observable, either directly or indirectly, including inputs in markets that are not considered active; and | ||||
Level 3—Valuations based on inputs that are unobservable and significant to the fair value measurement, and may include the Valuation Committee’s own assumptions on determining fair value of investments. | ||||
Inputs that are used in determining fair value of an investment may include price information, credit data, volatility statistics, and other factors. These inputs can be either observable or unobservable. The availability of observable inputs can vary between investments and is affected by various factors such as the type of investment and the volume and/or level of activity for that investment or similar investments in the marketplace. The inputs will be considered by the Valuation Committee, along with any other relevant factors in the calculation of an investment’s fair value. The Fund uses prices and inputs that are current as of the valuation date, which may include periods of market dislocations. During these periods, the availability of prices and inputs may be reduced for many investments. This condition could cause an investment to be reclassified between the various levels within the hierarchy. Investments falling into the Level 3 category may be classified as such due to a lack of market transparency and corroboration to support the quoted prices. Additionally, valuation models may be used as the pricing source for any remaining investments classified as Level 3. These models may rely on one or more significant unobservable inputs and/or significant assumptions by the Valuation Committee. Inputs used in valuations may include, but are not limited to, financial statement analysis, capital account balances, discount rates and estimated cash flows, and comparable entity data. | ||||
All investments are categorized as Level 1 as of the date of this report. | ||||
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual report. | ||||
The Global Industry Classification Standard (GICS®) was developed by and/or is the exclusive property of Morgan Stanley Capital International, Inc. (“MSCI”) and Standard & Poor’s Financial Services LLC (“S&P”). GICS is a service mark of MSCI and S&P and has been licensed for use by U.S. Bancorp Fund Services, LLC. | ||||